CureVac
CureVac AG, a pioneering biopharmaceutical company headquartered in Tübingen, Germany, is at the forefront of mRNA technology. Founded in 2000, CureVac has made significant strides in the development of innovative therapies and vaccines, particularly in the fields of oncology and infectious diseases. The company is renowned for its proprietary mRNA platform, which enables the creation of targeted treatments that harness the body’s own immune response. Notable achievements include the advancement of its COVID-19 vaccine candidate, which showcased the potential of mRNA in rapid vaccine development. With a strong market position, CureVac continues to expand its operational reach across Europe and North America, solidifying its role as a leader in the biopharmaceutical industry.
DitchCarbon Score
How does CureVac's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CureVac's score of 12 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CureVac's reported carbon emissions
CureVac, headquartered in Germany (DE), currently does not have publicly available carbon emissions data or specific reduction targets outlined. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in various climate commitments typical of the biopharmaceutical industry, focusing on sustainability and reducing environmental impact. As the industry increasingly prioritises climate action, CureVac may be expected to align with global standards and initiatives aimed at reducing greenhouse gas emissions in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CureVac is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
